Net Net Stock Overview

Subscribe

To see hundreds more international net nets, consider subscribing

Overview

Bone Biologics Corp
Healthcare
P/NCAV
0.14x
Ticker
BBLG
Exchange
NASDAQ
Country
United States
Close
1.6 $
Mkt Cap
421024 $
EV
-2.6M $
NCAV Burn Rate
51.1%
Current Ratio
4.5
Debt/Equity
0.0
EV/REV
N/Ax
EV/EBIT
0.3x
EV/FCF
0.3x
Dilution
67.8% p.A
Total Net Income
-68.1M $
Cheapness
8.0%
Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Profitability

positive values --- Average negative values

Margins

--- Average

Valuation

positive values --- Average negative values

Dilution

--- Average